نتائج البحث

تحتوي على الكلمات

فقط من النوع

POST-MARKET EVALUATION FOR THE SAFETY AND EFFECTIVENESS OF BREAST IMPLANTS دراسات الأجهزة الطبية

"A Randomised, Double-Blind, Placebo-Controlled, International, Multicentre, Phase III Study to Investigate the Efficacy and Safety of Ticagrelor and ASA Compared with ASA in the Prevention of Stroke and Death in Patients with Acute Ischaemic Stroke or Transient Ischaemic Attack[THALES - Acute STroke or Transient IscHaemic Attack Treated with TicAgreLor and ASA for PrEvention of Stroke and Death]" قائمة الدراسات السريرية المسجلة على الادوية

An Evaluation of the Saudi Healthcare Facilities Compliance to Develop a Procedure for Single-Use Medical Devices دراسات الأجهزة الطبية

Update of the Implementing Rule on LICENSING OF AUTHORISED REPRESENTATIVES (MDS-IR5) and the Guidance for Medical Device Authorised Representatives (MDS – G3). التعاميم

An observational study to monitor the efficacy and tolerability of levofloxacin 250 mg OD for treatment of simple lower UTI in Saudi Arabia قائمة الدراسات السريرية المسجلة على الادوية

A Phase 3, Randomized, Active Comparator, Double-Blind, Multi-Center Study to Compare the Efficacy, Safety and Tolerability of ITCA 650 to Sitagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes قائمة الدراسات السريرية المسجلة على الادوية

Randomized, two-way, two- period, single oral dose, open- label, crossover, bioequivalence study to compare Diclofenac Potassium powder for oral solution (50 mg diclofenac potassium) manufactured by Riyadh Pharma versus Catafast® powder for oral solution (50 mg diclofenac potassium) manufactured by Mipharm S.p.A., in healthy subjects under fasting condition. قائمة الدراسات السريرية المسجلة على الادوية

A multicenter, multinational, prospective, observational study to describe the clinical outcomes in patients with type 2 diabetes mellitus, treated with insulin glargine 300 U/mL (insulin glargine U300) before, during and after the period of Ramadan / ORION study قائمة الدراسات السريرية المسجلة على الادوية

Multicenter, first-line metastatic open-label prospective phase II trial evaluating the combination of Palbociclib (CDK 4/6 Inhibitor) and hormone therapy (Letrozole or Anastrozole) in women with luminal, HER2 negative advanced breast cancer: Evaluation of the prediction of individual treatment efficacy using infrared laser spectroscopy analysis on liquid biopsies (Quantum Optics) قائمة دراسات سريرية

Brightline-2: A Phase IIa/IIb, open-label, single-arm, multi-centre trial of brigimadlin (BI 907828) for treatment of patients with locally advanced / metastatic, MDM2 amplified, TP53 wild-type biliary tract adenocarcinoma, pancreatic ductal adenocarcinoma, or other selected solid tumours قائمة الدراسات السريرية المسجلة على الادوية